Investigation of Economic Financing Mode Management of Supply Chain in Pharmaceutical Enterprises

Authors

  • Yanyan Zhang School of Economy, Shandong Women’s University, Ji’nan, Shandong 250300, China
  • Ying Meng School of Economy, Shandong Women’s University, Ji’nan, Shandong 250300, China

Abstract

In China, small and medium-sized pharmaceutical enterprises are a special group of enterprises, which not only make a significant contribution to the national economy, but also play a significant role in the livelihood. However, due to the relatively small size of small and medium-sized enterprises, capital shortage is very likely to occur in the development process, and the high investment and high risk in the pharmaceutical industry can lead to financing difficulties. In order to solve the above problems, this paper briefly introduces the situation of capital shortage in the supply chain of small and medium-sized pharmaceutical enterprises and the receivable financing mode used to solve the problem of capital shortage. After that, five experts evaluated six factors influencing financing efficiency, namely, financing cost, risk, term, institutional norms, degree of freedom and capital
arrival rate, of enterprise X. A comprehensive fuzzy evaluation model is used to evaluate the efficiency and possibility of four receivables financing modes. The results showed that the weight A of the six factors; the efficiency of four receivables financing modes is non-recourse factoring mode, recourse factoring mode, pledge mode and securitization mode, from high to low. This led to the conclusion that enterprise X should give priority to the receivables financing mode without recourse factoring.

Keywords: pharmaceutical enterprise, receivable financing model, fuzzy comprehensive evaluation, supply chain

Cite As

Y. Zhang, Y. Meng, "Investigation of Economic Financing Mode Management of Supply Chain in Pharmaceutical
Enterprises", Engineering Intelligent Systems, vol. 27 no. 4, pp. 213-220, 2019.


Published

2019-12-01